To reduce the risks of drug development, KaiPharm, based in Seoul, South Korea, has developed KMAP, which combines artificial intelligence (AI) with transcriptome profiling to generate deep ...
The transcriptome has been attracting a lot of attention of late. Using RNA sequencing (RNA-Seq), researchers probe the RNA in cells and tissues to understand underlying biological processes.